Compare Roivant Sciences Ltd. Common Shares (ROIV) vs SPDR Kensho Final Frontiers ETF (ROKT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Roivant Sciences Ltd. Common Shares vs SPDR Kensho Final Frontiers ETF — how do they compare? Roivant Sciences Ltd. Common Shares trades at $34.21 (market cap $25.09B), while SPDR Kensho Final Frontiers ETF trades at $102.84 (market cap $176.19M). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 142.4× SPDR Kensho Final Frontiers ETF's market cap, and Roivant Sciences Ltd. Common Shares is trading nearer its 52-week high, SPDR Kensho Final Frontiers ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Roivant Sciences Ltd. Common Shares for 0 Days and SPDR Kensho Final Frontiers ETF for 8 Days on average.
| ROIV | ROKT | |
|---|---|---|
Market Cap | $25.09B | $176.19M |
Volume | 5,738,571 | 34,479 |
Sector | Health | Sector/Thematic |
52-Week High | $41.81 | $136.68 |
52-Week Low | $16.04 | $72.93 |
Typical Hold Time | 0 Days | 8 Days |
Enterprise Value | $21.36B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Roivant Sciences Ltd. Common Shares
Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →About SPDR Kensho Final Frontiers ETF
SPDR Kensho Final Frontiers ETF seeks exposure to companies supporting exploration of outer space and the deep sea. Its holdings include businesses involved in aerospace, defense, communications, research, and related technologies.
Read more on ROKT →
